State Street Corp Intra Cellular Therapies, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, State Street Corp holds 1,858,915 shares of ITCI stock, worth $162 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,858,915
Previous 1,802,251 3.14%
Holding current value
$162 Million
Previous $123 Million 10.12%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $3.85 Million - $4.58 Million
56,664 Added 3.14%
1,858,915 $136 Million
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $28.4 Million - $35 Million
-438,444 Reduced 19.57%
1,802,251 $123 Million
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $1.28 Million - $1.5 Million
19,845 Added 0.89%
2,240,695 $155 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $3.96 Million - $6.29 Million
85,415 Added 4.0%
2,220,850 $159 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $1.55 Million - $1.91 Million
29,730 Added 1.41%
2,135,435 $111 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $4.35 Million - $5.28 Million
79,477 Added 3.92%
2,105,705 $133 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $1.37 Million - $1.78 Million
31,225 Added 1.57%
2,026,228 $110 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $827,634 - $1.02 Million
18,780 Added 0.95%
1,995,003 $106 Million
Q3 2022

Nov 15, 2022
BUY
$42.7 - $59.99 $2.41 Million - $3.38 Million
56,408 Added 2.94%
1,976,223 $92 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $5.47 Million - $8.35 Million
127,285 Added 7.1%
1,919,815 $110 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $10.5 Million - $16.8 Million
269,892 Added 17.73%
1,792,530 $110 Million
Q4 2021

Feb 14, 2022
SELL
$35.2 - $53.42 $1.43 Million - $2.18 Million
-40,737 Reduced 2.61%
1,522,638 $79.7 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $1.82 Million - $2.69 Million
63,346 Added 4.22%
1,563,375 $58.3 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $479,641 - $728,465
16,370 Added 1.1%
1,500,029 $61.2 Million
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $3.97 Million - $5.09 Million
-128,942 Reduced 8.0%
1,483,659 $50.3 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $4.5 Million - $6.21 Million
192,683 Added 13.57%
1,612,601 $51.3 Million
Q3 2020

Nov 10, 2020
BUY
$17.61 - $31.86 $975,277 - $1.76 Million
55,382 Added 4.06%
1,419,918 $36.4 Million
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $1.86 Million - $3.46 Million
129,722 Added 10.51%
1,364,536 $35 Million
Q1 2020

May 11, 2020
BUY
$12.31 - $33.12 $15.2 Million - $40.9 Million
1,234,814 New
1,234,814 $19 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.21B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email